225 related articles for article (PubMed ID: 30821074)
1. A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice.
Shu Z; Gao Y; Zhang G; Zhou Y; Cao J; Wan D; Zhu X; Xiong W
J Cell Mol Med; 2019 May; 23(5):3616-3628. PubMed ID: 30821074
[TBL] [Abstract][Full Text] [Related]
2. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
[TBL] [Abstract][Full Text] [Related]
3. Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N; Li M; Hong W; Shao J; Xu H; Shimano H; Lu J; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2881-2889. PubMed ID: 29857051
[TBL] [Abstract][Full Text] [Related]
4. Hippo pathway cooperates with ChREBP to regulate hepatic glucose utilization.
Shu ZP; Yi GW; Deng S; Huang K; Wang Y
Biochem Biophys Res Commun; 2020 Sep; 530(1):115-121. PubMed ID: 32828272
[TBL] [Abstract][Full Text] [Related]
5. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response.
Shao D; Zhai P; Del Re DP; Sciarretta S; Yabuta N; Nojima H; Lim DS; Pan D; Sadoshima J
Nat Commun; 2014; 5():3315. PubMed ID: 24525530
[TBL] [Abstract][Full Text] [Related]
6. Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program.
Ning J; Hong T; Ward A; Pi J; Liu Z; Liu HY; Cao W
Endocrinology; 2011 Jun; 152(6):2247-55. PubMed ID: 21447637
[TBL] [Abstract][Full Text] [Related]
7. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
[TBL] [Abstract][Full Text] [Related]
8. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
Du R; Xue J; Wang HB; Zhang Y; Xie ML
Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823
[TBL] [Abstract][Full Text] [Related]
9. RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.
Cui XB; Luan JN; Chen SY
J Biol Chem; 2015 Aug; 290(33):20387-95. PubMed ID: 26134570
[TBL] [Abstract][Full Text] [Related]
10. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
11. JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism.
Wei Q; Zhou B; Yang G; Hu W; Zhang L; Liu R; Li M; Wang K; Gu HF; Guan Y; Zhu Z; Zheng H; Peng J; Li L
Cell Death Dis; 2018 Aug; 9(9):859. PubMed ID: 30154417
[TBL] [Abstract][Full Text] [Related]
12. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c.
Teran-Garcia M; Adamson AW; Yu G; Rufo C; Suchankova G; Dreesen TD; Tekle M; Clarke SD; Gettys TW
Biochem J; 2007 Mar; 402(3):591-600. PubMed ID: 17313375
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Liver Regeneration After Partial Hepatectomy in Sterol Regulatory Element-Binding Protein (SREBP)-1c-Null Mice is Associated with Increased Hepatocellular Cholesterol Availability.
Peng J; Yu J; Xu H; Kang C; Shaul PW; Guan Y; Zhang X; Su W
Cell Physiol Biochem; 2018; 47(2):784-799. PubMed ID: 29807364
[TBL] [Abstract][Full Text] [Related]
16. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.
Li Y; Xu S; Mihaylova MM; Zheng B; Hou X; Jiang B; Park O; Luo Z; Lefai E; Shyy JY; Gao B; Wierzbicki M; Verbeuren TJ; Shaw RJ; Cohen RA; Zang M
Cell Metab; 2011 Apr; 13(4):376-388. PubMed ID: 21459323
[TBL] [Abstract][Full Text] [Related]
17. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
[TBL] [Abstract][Full Text] [Related]
18. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
[TBL] [Abstract][Full Text] [Related]
20. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
